Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pollak

Showing results (171-180 of 196) with videos related to

Pageof 20
Sort By:
The Journal of Laboratory and Clinical Medicine|January 1, 1985
Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrodK S Kant, V E Pollak, A Dosekun, et al.
Clinical Nephrology|October 1, 1985
Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin)X H Du, P Glas-Greenwalt, K S Kant, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1990
Anthropometric norms for the dialysis populationE E Nelson, C D Hong, A L Pesce, et al.
American Journal of Nephrology|January 1, 1981
Antibody to Tamm-Horsfall protein after acute tubular necrosisB S Ooi, M A Weiss, K S Kant, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1986
Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpuraP Glas-Greenwalt, J M Hall, T W Panke, et al.
Thrombosis Research|September 15, 1982
Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observationsK S Kant, A K Dosekun, K G Chandran, et al.
Clinical Biochemistry|October 1, 1980
Renal tubular interactions of proteinsA J Pesce, D H Clyne, V E Pollak, et al.
Medicine|March 1, 1981
Glomerular thrombosis in systemic lupus erythematosus: prevalence and significanceK S Kant, V E Pollak, M A Weiss, et al.
American Journal of Nephrology|January 1, 1986
Effect of first and subsequent use of hemodialyzers on patient well-being. Analysis of the incidence of symptoms and events and description of a syndrome associated with new dialyzer useM D Robson, R Charoenpanich, K S Kant, et al.
Prostaglandins|August 1, 1986
Beneficial effects of polyunsaturated fatty acids in partially nephrectomized ratsU O Barcelli, J Miyata, Y Ito, et al.
Pageof 20

Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
The Journal of Laboratory and Clinical Medicine|January 1, 1985
Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrodK S Kant, V E Pollak, A Dosekun, et al.
Clinical Nephrology|October 1, 1985
Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin)X H Du, P Glas-Greenwalt, K S Kant, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1990
Anthropometric norms for the dialysis populationE E Nelson, C D Hong, A L Pesce, et al.
American Journal of Nephrology|January 1, 1981
Antibody to Tamm-Horsfall protein after acute tubular necrosisB S Ooi, M A Weiss, K S Kant, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1986
Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpuraP Glas-Greenwalt, J M Hall, T W Panke, et al.
Thrombosis Research|September 15, 1982
Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observationsK S Kant, A K Dosekun, K G Chandran, et al.
Clinical Biochemistry|October 1, 1980
Renal tubular interactions of proteinsA J Pesce, D H Clyne, V E Pollak, et al.
Medicine|March 1, 1981
Glomerular thrombosis in systemic lupus erythematosus: prevalence and significanceK S Kant, V E Pollak, M A Weiss, et al.
American Journal of Nephrology|January 1, 1986
Effect of first and subsequent use of hemodialyzers on patient well-being. Analysis of the incidence of symptoms and events and description of a syndrome associated with new dialyzer useM D Robson, R Charoenpanich, K S Kant, et al.
Prostaglandins|August 1, 1986
Beneficial effects of polyunsaturated fatty acids in partially nephrectomized ratsU O Barcelli, J Miyata, Y Ito, et al.
Pageof 20